Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU1-136P (RNA, U1 small nuclear 136, pseudogene) is a genomic locus annotated as a pseudogene member of the U1 small nuclear RNA (snRNA) gene family. U1 snRNA itself is essential for pre-mRNA splicing and gene expression regulation within the spliceosome. However, pseudogenes like RNU1-136P are generally regarded as non-functional gene copies. Recent studies indicate that some U1 snRNA pseudogenes may be transcriptionally active and could potentially generate variant snRNAs with regulatory effects on pre-mRNA processing, but there is no direct evidence for such a function in RNU1-136P specifically. It is not considered a receptor, enzyme, or therapeutic target, and there are no drugs known to interact with it or specific disease associations. It mainly serves as a genomic feature of interest within the broader study of non-coding RNA and pseudogene biology.\n\nKey points:\n- RNU1-136P is a non-coding pseudogene, not a protein or functional receptor/enzyme.\n- It is not a validated or actionable therapeutic target.\n- There is no direct evidence supporting a biomedical or pharmacological role for RNU1-136P specifically.\n- Presence of pseudogene-derived RNAs elsewhere raises interest in possible regulatory RNA functions, but this is not established here.\n\nIf you need information on the canonical U1 snRNA (functional gene), please clarify, as that would refer to a different, essential non-coding RNA gene (RNU1-1).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 136, pseudogene (RNU1-136P).